{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T15:01:24Z","timestamp":1780758084425,"version":"3.54.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s13760-025-02870-4","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T07:36:10Z","timestamp":1755934570000},"page":"529-535","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical value of serum miR-451 in early diagnosis of multiple system atrophy from parkinson\u2019s disease and outcomes prediction"],"prefix":"10.1007","volume":"126","author":[{"given":"Tingyan","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzheng","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"issue":"7794","key":"2870_CR1","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X et al (2020) Discriminating alpha-synuclein strains in parkinson\u2019s disease and multiple system atrophy. Nature 578(7794):273\u2013277. https:\/\/doi.org\/10.1038\/s41586-020-1984-7","journal-title":"Nature"},{"issue":"1","key":"2870_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-021-00501-z","volume":"16","author":"S Koga","year":"2021","unstructured":"Koga S, Sekiya H, Kondru N, Ross OA, Dickson DW (2021) Neuropathology and molecular diagnosis of synucleinopathies. Mol Neurodegener 16(1):83. https:\/\/doi.org\/10.1186\/s13024-021-00501-z","journal-title":"Mol Neurodegener"},{"issue":"7794","key":"2870_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41586-020-1984-7","volume":"578","author":"M Shahnawaz","year":"2020","unstructured":"Shahnawaz M, Mukherjee A, Pritzkow S, Mendez N, Rabadia P, Liu X et al (2020) Discriminating \u03b1-synuclein strains in Parkinson\u2019s disease and multiple system atrophy. Nature 578(7794):273\u2013277. https:\/\/doi.org\/10.1038\/s41586-020-1984-7","journal-title":"Nature"},{"issue":"4","key":"2870_CR4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/WCO.0000000000001285","volume":"37","author":"I Stankovic","year":"2024","unstructured":"Stankovic I, Kuijpers M, Kaufmann H (2024) An update on multiple system atrophy. Curr Opin Neurol 37(4):400\u2013408. https:\/\/doi.org\/10.1097\/WCO.0000000000001285","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"2870_CR5","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1136\/jnnp.66.4.541","volume":"66","author":"V Fetoni","year":"1999","unstructured":"Fetoni V, Soliveri P, Monza D, Testa D, Girotti F (1999) Affective symptoms in multiple system atrophy and Parkinson\u2019s disease: response to levodopa therapy. J Neurol Neurosurg Psychiatry 66(4):541\u2013544. https:\/\/doi.org\/10.1136\/jnnp.66.4.541","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2870_CR6","doi-asserted-by":"publisher","first-page":"1210220","DOI":"10.3389\/fneur.2023.1210220","volume":"14","author":"M Goolla","year":"2023","unstructured":"Goolla M, Cheshire WP, Ross OA, Kondru N (2023) Diagnosing multiple system atrophy: current clinical guidance and emerging molecular biomarkers. Front Neurol 14:1210220. https:\/\/doi.org\/10.3389\/fneur.2023.1210220","journal-title":"Front Neurol"},{"issue":"3","key":"2870_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2169\/internalmedicine.4836-20","volume":"60","author":"C Ishida","year":"2021","unstructured":"Ishida C, Takahashi K, Kato-Motozaki Y, Tagami A, Komai K (2021) Effectiveness of Levodopa in patients with multiple system atrophy and associated clinicopathological features. Internal medicine (Tokyo. Japan) 60(3):367\u2013372. https:\/\/doi.org\/10.2169\/internalmedicine.4836-20","journal-title":"Japan)"},{"issue":"2","key":"2870_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10286-022-00853-6","volume":"32","author":"C Eckhardt","year":"2022","unstructured":"Eckhardt C, Krismer F, Donnemiller E, Eschlb\u00f6ck S, Fanciulli A, Raccagni C et al (2022) Cardiac sympathetic innervation in Parkinson\u2019s disease versus multiple system atrophy. Clin Auton Res 32(2):103\u2013114. https:\/\/doi.org\/10.1007\/s10286-022-00853-6","journal-title":"Clin Auton Res"},{"key":"2870_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031879","author":"DH Kwon","year":"2022","unstructured":"Kwon DH, Hwang JS, Kim SG, Jang YE, Shin TH, Lee G (2022) Cerebrospinal fluid metabolome in Parkinson\u2019s disease and multiple system atrophy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23031879","journal-title":"Int J Mol Sci"},{"issue":"5","key":"2870_CR10","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.crad.2015.01.005","volume":"70","author":"N Ramli","year":"2015","unstructured":"Ramli N, Nair SR, Ramli NM, Lim SY (2015) Differentiating multiple-system atrophy from Parkinson\u2019s disease. Clin Radiol 70(5):555\u2013564. https:\/\/doi.org\/10.1016\/j.crad.2015.01.005","journal-title":"Clin Radiol"},{"issue":"5","key":"2870_CR11","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1007\/s00415-024-12269-5","volume":"271","author":"M Liu","year":"2024","unstructured":"Liu M, Wang Z, Shang H (2024) Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials. J Neurol 271(5):2324\u20132344. https:\/\/doi.org\/10.1007\/s00415-024-12269-5","journal-title":"J Neurol"},{"issue":"13","key":"2870_CR12","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.neuron.2024.04.002","volume":"112","author":"R Chia","year":"2024","unstructured":"Chia R, Ray A, Shah Z, Ding J, Ruffo P, Fujita M et al (2024) Genome sequence analyses identify novel risk loci for multiple system atrophy. Neuron 112(13):2142\u201356e5. https:\/\/doi.org\/10.1016\/j.neuron.2024.04.002","journal-title":"Neuron"},{"key":"2870_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.632891","volume":"13","author":"A Vallelunga","year":"2021","unstructured":"Vallelunga A, Iannitti T, Capece S, Somma G, Russillo MC, Foubert-Samier A et al (2021) Serum miR-96-5P and miR-339-5P are potential biomarkers for multiple system atrophy and parkinson\u2019s disease. Front Aging Neurosci 13:632891. https:\/\/doi.org\/10.3389\/fnagi.2021.632891","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"2870_CR14","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1007\/s11033-019-04614-z","volume":"46","author":"A Vallelunga","year":"2019","unstructured":"Vallelunga A, Iannitti T, Dati G, Capece S, Maugeri M, Tocci E et al (2019) Serum miR-30c-5p is a potential biomarker for multiple system atrophy. Mol Biol Rep 46(2):1661\u20131666. https:\/\/doi.org\/10.1007\/s11033-019-04614-z","journal-title":"Mol Biol Rep"},{"key":"2870_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2014.00156","volume":"8","author":"A Vallelunga","year":"2014","unstructured":"Vallelunga A, Ragusa M, Di Mauro S, Iannitti T, Pilleri M, Biundo R et al (2014) Identification of circulating micrornas for the differential diagnosis of Parkinson\u2019s disease and multiple system atrophy. Front Cell Neurosci 8:156. https:\/\/doi.org\/10.3389\/fncel.2014.00156","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"2870_CR16","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3892\/mmr.2017.7995","volume":"17","author":"K Kume","year":"2018","unstructured":"Kume K, Iwama H, Deguchi K, Ikeda K, Takata T, Kokudo Y et al (2018) Serum MicroRNA expression profiling in patients with multiple system atrophy. Mol Med Rep 17(1):852\u2013860. https:\/\/doi.org\/10.3892\/mmr.2017.7995","journal-title":"Mol Med Rep"},{"key":"2870_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4409212","volume":"2021","author":"HA Al-Rawaf","year":"2021","unstructured":"Al-Rawaf HA, Alghadir AH, Gabr SA (2021) Circulating MicroRNAs and molecular oxidative stress in older adults with neuroprogression disorders. Dis Markers 2021:4409212. https:\/\/doi.org\/10.1155\/2021\/4409212","journal-title":"Dis Markers"},{"issue":"12","key":"2870_CR18","doi-asserted-by":"publisher","first-page":"10481","DOI":"10.1007\/s12035-024-04207-3","volume":"61","author":"S Bai","year":"2024","unstructured":"Bai S, Zhang G, Chen S, Wu X, Li J, Wang J et al (2024) Microrna-451 regulates angiogenesis in intracerebral hemorrhage by targeting macrophage migration inhibitory factor. Mol Neurobiol 61(12):10481\u201310499. https:\/\/doi.org\/10.1007\/s12035-024-04207-3","journal-title":"Mol Neurobiol"},{"issue":"1","key":"2870_CR19","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2174\/1567202617666191223150510","volume":"17","author":"N Weng","year":"2020","unstructured":"Weng N, Sun J, Kuang S, Lan H, He Q, Yang H et al (2020) Microrna-451 aggravates kainic acid-induced seizure and neuronal apoptosis by targeting GDNF. Curr Neurovasc Res 17(1):50\u201357. https:\/\/doi.org\/10.2174\/1567202617666191223150510","journal-title":"Curr Neurovasc Res"},{"key":"2870_CR20","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fnmol.2016.00069","volume":"9","author":"Y Chen","year":"2016","unstructured":"Chen Y, Wei Q, Chen X, Li C, Cao B, Ou R et al (2016) Aberration of miRNAs expression in leukocytes from sporadic amyotrophic lateral sclerosis. Front Mol Neurosci 9:69. https:\/\/doi.org\/10.3389\/fnmol.2016.00069","journal-title":"Front Mol Neurosci"},{"issue":"12","key":"2870_CR21","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/S1474-4422(24)00396-X","volume":"23","author":"F Krismer","year":"2024","unstructured":"Krismer F, Fanciulli A, Meissner WG, Coon EA, Wenning GK (2024) Multiple system atrophy: advances in pathophysiology, diagnosis, and treatment. Lancet Neurol 23(12):1252\u20131266. https:\/\/doi.org\/10.1016\/S1474-4422(24)00396-X","journal-title":"Lancet Neurol"},{"issue":"6","key":"2870_CR22","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1002\/mds.29005","volume":"37","author":"GK Wenning","year":"2022","unstructured":"Wenning GK, Stankovic I, Vignatelli L, Fanciulli A, Calandra-Buonaura G, Seppi K et al (2022) The movement disorder society criteria for the diagnosis of multiple system atrophy. Mov Disord 37(6):1131\u20131148. https:\/\/doi.org\/10.1002\/mds.29005","journal-title":"Mov Disord"},{"key":"2870_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23137167","author":"PTB Ho","year":"2022","unstructured":"Ho PTB, Clark IM, Le LTT (2022) Microrna-based diagnosis and therapy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23137167","journal-title":"Int J Mol Sci"},{"key":"2870_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-0716-2823-2_1","volume":"2595","author":"A Vishnoi","year":"2023","unstructured":"Vishnoi A, Rani S (2023) Mirna biogenesis and regulation of diseases: an updated overview. Methods in molecular biology. (Clifton NJ) 2595:1\u201312. https:\/\/doi.org\/10.1007\/978-1-0716-2823-2_1","journal-title":"(Clifton NJ)"},{"key":"2870_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021009","author":"H Wang","year":"2023","unstructured":"Wang H, Ho C (2023) The human pre-miRNA distance distribution for exploring disease association. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms24021009","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2870_CR26","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.clinph.2019.09.004","volume":"130","author":"Y Terao","year":"2019","unstructured":"Terao Y, Tokushige SI, Inomata-Terada S, Fukuda H, Yugeta A, Ugawa Y (2019) Differentiating early Parkinson\u2019s disease and multiple system atrophy with parkinsonism by saccade velocity profiles. Clin Neurophysiol 130(12):2203\u20132215. https:\/\/doi.org\/10.1016\/j.clinph.2019.09.004","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"2870_CR27","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/brain\/awab017","volume":"144","author":"Y Miki","year":"2021","unstructured":"Miki Y, Tsushima E, Foti SC, Strand KM, Asi YT, Yamamoto AK et al (2021) Identification of multiple system atrophy mimicking Parkinson\u2019s disease or progressive supranuclear palsy. Brain 144(4):1138\u20131151. https:\/\/doi.org\/10.1093\/brain\/awab017","journal-title":"Brain"},{"issue":"Suppl 1","key":"2870_CR28","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.parkreldis.2017.07.033","volume":"46","author":"DW Dickson","year":"2018","unstructured":"Dickson DW (2018) Neuropathology of Parkinson disease. Parkinsonism Relat Disord 46(Suppl 1):S30\u2013s3. https:\/\/doi.org\/10.1016\/j.parkreldis.2017.07.033","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"2870_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10286-023-00934-0","volume":"33","author":"A Ferreiros","year":"2023","unstructured":"Ferreiros A, Castillo-Torres SA, Merello M (2023) Motor assessment of patients with multiple system atrophy: underuse of the unified multiple system atrophy rating scale (UMSARS). Clin Auton Research: Official J Clin Auton Res Soc 33(2):143\u2013148. https:\/\/doi.org\/10.1007\/s10286-023-00934-0","journal-title":"Clin Auton Research: Official J Clin Auton Res Soc"},{"key":"2870_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clineuro.2017.10.039","volume":"164","author":"LB Barcelos","year":"2018","unstructured":"Barcelos LB, Saad F, Giacominelli C, Saba RA, de Carvalho Aguiar PM, Silva SMA et al (2018) Neuropsychological and clinical heterogeneity of cognitive impairment in patients with multiple system atrophy. Clin Neurol Neurosurg 164:121\u2013126. https:\/\/doi.org\/10.1016\/j.clineuro.2017.10.039","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"2870_CR31","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1007\/s12311-023-01642-1","volume":"23","author":"C Makawita","year":"2024","unstructured":"Makawita C, Ananthavarathan P, de Silva R, Malek N (2024) A systematic review of the spectrum and prevalence of non-motor symptoms in multiple system atrophy. Cerebellum 23(4):1642\u20131650. https:\/\/doi.org\/10.1007\/s12311-023-01642-1","journal-title":"Cerebellum"},{"issue":"1","key":"2870_CR32","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12916-022-02645-1","volume":"20","author":"L Zhang","year":"2022","unstructured":"Zhang L, Hou Y, Cao B, Wei Q, Ou R, Liu K et al (2022) Longitudinal evolution of motor and non-motor symptoms in early-stage multiple system atrophy: a 2-year prospective cohort study. BMC Med 20(1):446. https:\/\/doi.org\/10.1186\/s12916-022-02645-1","journal-title":"BMC Med"},{"issue":"5\u20136","key":"2870_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000507292","volume":"19","author":"YJ Jung","year":"2019","unstructured":"Jung YJ, Kim HJ, Yoo D, Choi JH, Im JH, Yang HJ et al (2019) Various motor and non-motor symptoms in early multiple system atrophy. Neurodegener Dis 19(5\u20136):238\u2013243. https:\/\/doi.org\/10.1159\/000507292","journal-title":"Neurodegener Dis"},{"issue":"5","key":"2870_CR34","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1017\/cjn.2016.261","volume":"43","author":"L Zhou","year":"2016","unstructured":"Zhou L, Jiang Y, Zhu C, Ma L, Huang Q, Chen X (2016) Oxidative stress and environmental exposures are associated with multiple system atrophy in Chinese patients. Can J Neurol Sci 43(5):703\u2013709. https:\/\/doi.org\/10.1017\/cjn.2016.261","journal-title":"Can J Neurol Sci"},{"key":"2870_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012603","author":"D Mantle","year":"2022","unstructured":"Mantle D, Hargreaves IP (2022) Mitochondrial dysfunction and neurodegenerative disorders: role of nutritional supplementation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms232012603","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2870_CR36","doi-asserted-by":"publisher","first-page":"3588","DOI":"10.1016\/j.bbadis.2018.09.018","volume":"1864","author":"G Monzio Compagnoni","year":"2018","unstructured":"Monzio Compagnoni G, Kleiner G, Bordoni A, Fortunato F, Ronchi D, Salani S et al (2018) Mitochondrial dysfunction in fibroblasts of multiple system atrophy. Biochimica et Biophysica Acta (BBA) 1864(12):3588\u20133597. https:\/\/doi.org\/10.1016\/j.bbadis.2018.09.018","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"2870_CR37","doi-asserted-by":"publisher","first-page":"1214677","DOI":"10.3389\/fimmu.2023.1214677","volume":"14","author":"M Lenska-Mieciek","year":"2023","unstructured":"Lenska-Mieciek M, Madetko-Alster N, Alster P, Krolicki L, Fiszer U, Koziorowski D (2023) Inflammation in multiple system atrophy. Front Immunol 14:1214677. https:\/\/doi.org\/10.3389\/fimmu.2023.1214677","journal-title":"Front Immunol"},{"key":"2870_CR38","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.parkreldis.2022.05.018","volume":"100","author":"AS Blaise","year":"2022","unstructured":"Blaise AS, Cuvelier E, Carri\u00e8re N, Devos D, Moreau F, Defebvre L et al (2022) Use of levodopa-carbidopa intestinal gel to treat patients with multiple system atrophy. Parkinsonism Relat Disord 100:41\u201344. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.05.018","journal-title":"Parkinsonism Relat Disord"},{"key":"2870_CR39","doi-asserted-by":"publisher","DOI":"10.2174\/0115665240327822241104060015","author":"J Zhu","year":"2024","unstructured":"Zhu J, Feng Y, Zhang L, Pang X, He S, Fang L (2024) miR-144\/451: a regulatory role in inflammation. Curr Mol Med. https:\/\/doi.org\/10.2174\/0115665240327822241104060015","journal-title":"Curr Mol Med"},{"issue":"17","key":"2870_CR40","doi-asserted-by":"publisher","first-page":"7156","DOI":"10.18632\/aging.204287","volume":"14","author":"Y Chen","year":"2022","unstructured":"Chen Y, Li X, Shi L, Ma P, Wang W, Wu N et al (2022) Combination of 7-O-geranylquercetin and microRNA-451 enhances antitumor effect of adriamycin by reserving P-gp-mediated drug resistance in breast cancer. Aging 14(17):7156\u20137169. https:\/\/doi.org\/10.18632\/aging.204287","journal-title":"Aging"},{"issue":"1","key":"2870_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ene.13412","volume":"25","author":"AB Deutschl\u00e4nder","year":"2018","unstructured":"Deutschl\u00e4nder AB, Ross OA, Dickson DW, Wszolek ZK (2018) Atypical parkinsonian syndromes: a general neurologist\u2019s perspective. Eur J Neurol 25(1):41\u201358. https:\/\/doi.org\/10.1111\/ene.13412","journal-title":"Eur J Neurol"},{"issue":"12","key":"2870_CR42","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.3174\/ajnr.A8313","volume":"45","author":"G Keir","year":"2024","unstructured":"Keir G, Roytman M, Mashriqi F, Shahsavarani S, Franceschi AM (2024) Atypical parkinsonian syndromes: structural, functional, and molecular imaging features. AJNR Am J Neuroradiol 45(12):1865\u20131877. https:\/\/doi.org\/10.3174\/ajnr.A8313","journal-title":"AJNR Am J Neuroradiol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-025-02870-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-025-02870-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-025-02870-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T14:43:46Z","timestamp":1780757026000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-025-02870-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2870"],"URL":"https:\/\/doi.org\/10.1007\/s13760-025-02870-4","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"14 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}